Lilly Eli & Co

-

Stock Issuer and Owners

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Latest Filings
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Lilly Eli & Co
TickerLLY
CIK #0000059478
CUSIP532457108
SectorLife Sciences - Pharmaceutical Preparations
AddressLilly Corporate Ctr Drop Code 1112, Indianapolis, IN 46285
Source [EDGAR]
CIK Filing 2011 - 2024
[0000059478] 10-K
[0000059478] 10-Q
[0000059478] 3
[0000059478] 4
[0000059478] 5
[0000059478] 8-K
[0000059478] SC 13D
[0000059478] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Eli Lilly & Co Akouos Inc [2022-10-27] 25.5
Eli Lilly & Co Immunocore Holdings PLC [2022-02-10] 5.8
Eli Lilly & Co Foghorn Therapeutics Inc [2021-12-13] 0.7
Eli Lilly & Co Proqr Therapeutics NV [2021-09-10] 5.6
Eli Lilly & Co Sigilon Therapeutics Inc [2021-02-12] 8.8
Eli Lilly & Co AC Immune Sa [2021-02-12] 5.0
Eli Lilly & Co Avidity Biosciences Inc [2021-02-12] 6.2
Eli Lilly & Co Precision Biosciences Inc [2021-01-08] 7.165
Eli Lilly & Co Prevail Therapeutics Inc [2020-12-22] 53.3
PNC Financial Services Group Inc Eli Lilly & Co [2020-02-14] 5.43
Eli Lilly & Co Dermira Inc [2020-01-10] 12.9
Lilly Eli & Co Elanco Animal Health Inc [2019-02-14] 80.2
Lilly Eli & Co Loxo Oncology Inc [2019-01-15] 6.6
Lilly Eli & Co Dicerna Pharmaceuticals Inc [2018-12-20] 8.6
Lilly Eli & Co Zymeworks Inc [2018-02-14] 15.6
Lilly Eli & Co LEAP Therapeutics Inc [2017-11-22] 17.5
Wellington Management Group LLP Lilly Eli & Co [2017-02-09] 5.15
Lilly Eli & Co Colucid Pharmaceuticals Inc [2017-01-27] 35.0
Lilly Eli & Co Lilly Eli & Co [2016-04-22] 19.2
Vanguard Group Inc Lilly Eli & Co [2016-02-11] 5.4
Lilly Eli & Co Ignyta Inc [2015-11-16] 8.4
Lilly Eli & Co Cerulean Pharma Inc [2015-02-17] 11.7
Lilly Eli & Co Zosano Pharma Corp [2015-02-09] 11.5
Lilly Eli & Co Coherus Biosciences Inc [2014-11-24] 0.1
PRIMECAP Management Co/CA/ Lilly Eli & Co [2014-03-07] 5.0
Wellington Management Co LLP Lilly Eli & Co [2014-02-14] 5.64
Form 3/4/5 Filer 2011 - 2024
Jonsson Patrik
ELI LILLY & Co
Rau Diogo
Lilly Endowment Inc
Luciano Juan R
Alvarez Ralph
Fyrwald J Erik
Johnson Kimberly H
Zakrowski Donald A
Sulzberger Gabrielle
Hedley Mary Lynne
Tai Jackson P
Weems Alonzo
Hernandez Edgardo
Dozier Eric
Norton Johna
Van Naarden Jacob
Yuffa Ilya
White Anne E.
Skovronsky Daniel
Ricks David A
Pusey Leigh Ann
Mason Michael B
Hakim Anat
Ashkenazi Anat
Kearny Acquisition Corp
Akouos, Inc.
Baicker Katherine
Jackson Jamere
Kaelin William G Jr
Runge Marschall S
Walker Karen
Fry Stephen F
Eskew Michael L
Barnes Melissa S
O'Neill Myles
Shah Aarti S.
Smiley Joshua L
Zulueta Alfonso G
Tyto Acquisition Corp
Prevail Therapeutics Inc.
Sigilon Therapeutics, Inc.
Seifert Kathi P
Bertozzi Carolyn R
Avidity Biosciences, Inc.
Dermira, Inc.
Bald Eagle Acquisition Corp
Harrington Michael J
Shaw Christi
Marram Ellen R
Elanco Animal Health Inc
Conterno Enrique A
Zymeworks BC Inc.
Simmons Jeffrey N
LEAP Therapeutics Inc
Mahony Susan
Lundberg Jan M
Rice Derica W
Crowe Maria A
Lechleiter John C
Hoover R David
Prendergast Franklyn G
CoLucid Pharmaceuticals, Inc.
Walsh Fionnuala M
Aeglea BioTherapeutics, Inc.
Peterson Barton R
Horn Karen N
Zosano Pharma Corp
Oberhelman Douglas R
Coherus BioSciences, Inc.
Lilly Ventures Fund I LLC
Dare Bioscience, Inc.
Tapiero Jacques
Bischoff Winfried F W Sir
Gilman Alfred G
Armitage Robert A
Nobles Anne
Hanish Arnold C
Carmine Bryce D.
Deane Frank M
Form 13F Holdings
Firm Period DFND Voting Shares
Lilly Endowment Inc [2023-03-31] SOLE 102,543,810.0 102,543,810.0
Vanguard Group Inc [2023-03-31] SOLE 0.0 66,561,861.0
BlackRock Inc. [2023-03-31] SOLE 58,820,711.0 65,569,577.0
OFI Invest Asset Management [2023-03-31] SOLE 53,035,381.0 53,035,381.0
PNC Financial Services Group Inc [2023-03-31] DFND 1,588,709.0 51,621,756.0
State Street Corp [2023-03-31] DFND 28,098,511.0 33,236,143.0
FMR LLC [2023-03-31] DFND 29,867,941.0 32,007,276.0
Capital World Investors [2023-03-31] DFND 27,558,547.0 27,588,540.0
PRIMECAP Management Co/CA/ [2023-03-31] SOLE 24,475,380.0 25,367,550.0
Price T Rowe Associates Inc /MD/ [2023-03-31] SOLE 10,207,181.0 21,653,693.0
Wellington Management Group LLP [2023-03-31] DFND 0.0 20,324,267.0
State Farm Mutual Automobile Insurance Co [2023-03-31] SOLE 17,410,725.0 17,410,725.0
Geode Capital Management LLC [2023-03-31] DFND 14,843,005.0 14,867,424.0
Morgan Stanley [2023-03-31] DFND 6,583,413.0 12,143,459.0
Northern Trust Corp [2023-03-31] DFND 2,689,290.0 10,316,459.0
Bank of America Corp /DE/ [2023-03-31] DFND 1,670,129.0 10,253,448.0
JPMorgan Chase & Co [2023-03-31] DFND 7,216,736.0 8,975,736.0
Bank of New York Mellon Corp [2023-03-31] DFND 7,064,984.0 8,610,703.0
Jennison Associates LLC [2023-03-31] DFND 7,862,032.0 8,370,048.0
Capital International Investors [2023-03-31] DFND 6,523,672.0 6,537,911.0
Capital Research Global Investors [2023-03-31] DFND 6,128,696.0 6,128,951.0
Legal & General Group Plc [2023-03-31] DFND 4,932,923.0 5,910,968.0
Goldman Sachs Group Inc [2023-03-31] DFND 5,275,243.0 5,823,106.0
Amundi [2023-03-31] DFND 5,518,680.0 5,682,813.0
Nuveen Asset Management LLC [2023-03-31] DFND 5,159,198.0 5,159,403.0
Ameriprise Financial Inc [2023-03-31] DFND 0.0 5,082,132.0
Susquehanna International Group LLP [2023-03-31] DFND 444,772.0 4,894,572.0
AllianceBernstein LP [2023-03-31] DFND 4,272,161.0 4,553,514.0
Charles Schwab Investment Management Inc [2023-03-31] SOLE 4,313,977.0 4,313,984.0
Fisher Asset Management LLC [2023-03-31] DFND 3,913,937.0 4,102,942.0
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com